- Report
- August 2025
- 188 Pages
Global
From €3991EUR$4,500USD£3,462GBP
- Report
- August 2025
- 4113 Pages
Global
From €4390EUR$4,950USD£3,808GBP
- Report
- August 2025
- 183 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Report
- August 2025
- 194 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Report
- August 2025
- 193 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Report
- August 2025
- 192 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Report
- August 2025
- 189 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Report
- August 2025
- 199 Pages
Global
From €3144EUR$3,545USD£2,727GBP
€3494EUR$3,939USD£3,030GBP
- Book
- October 2022
- 384 Pages
- Book
- May 2023
North America
- Book
- August 2020
North America
- Book
- December 2018
North America
- Book
- February 2017
North America
- Book
- May 2021
North America
- Book
- October 2019
North America

Radiomics is a field of medical imaging that uses quantitative analysis of medical images to extract and analyze data from medical images. This data can be used to identify and characterize disease, predict patient outcomes, and monitor treatment response. Radiomics is used in a variety of medical imaging modalities, including computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET).
Radiomics has the potential to improve the accuracy of diagnosis and prognosis, as well as to provide more personalized treatment plans. It can also be used to identify biomarkers that can be used to monitor disease progression and treatment response.
Companies in the Radiomics market include Philips Healthcare, Siemens Healthineers, GE Healthcare, Canon Medical Systems, and Toshiba Medical Systems. Show Less Read more